Screening patients for use of illegal drugs

A Siemens Healthcare Diagnostics product story
Edited by the Laboratorytalk editorial team May 25, 2005

Nine new tests for drugs of abuse including cannabinoid, opiate, benzodiazepine, methadone, phencyclidine, propoxyphene, cocaine, amphetamines, and barbiturate are available for chemistry analysers

Bayer Diagnostics announces a significant menu expansion for its leading automated chemistry systems, the Advia 1650 and Advia 2400 analysers.

Nine new tests for drugs of abuse including cannabinoid, opiate (300 and 2000), benzodiazepine, methadone, phencyclidine, propoxyphene, cocaine, amphetamines and barbiturate are now available on these analysers, offering laboratory professionals the ability to perform initial patient screening for use of illegal drugs.

Bayer's Advia 1650 and 2400 chemistry systems provide high speed, automation-compatible testing platforms with a comprehensive menu of almost 70 assays including general and special chemistry, specific protein, therapeutic drug monitoring, as well as drug of abuse methods.

With open channels for user-defined applications, Advia chemistry systems offer unparalleled, cost-effective workstation consolidation, says Bayer.

Not what you're looking for? Search the site.

Back to top Back to top

Contact Siemens Healthcare Diagnostics

Related Stories

Contact Siemens Healthcare Diagnostics

 

Newsletter sign up

Request your free weekly copy of the Laboratorytalk email newsletter ...

Search by company

A Pro-talk Publication

A Pro-talk publication